Cargando…

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial

Fibrodysplasia ossificans progressiva (FOP) is an ultra‐rare genetic disorder characterized by progressive heterotopic ossification (HO), often heralded by flare‐ups, leading to reduced movement and life expectancy. This placebo‐controlled, double‐blind trial (NCT02190747) evaluated palovarotene, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pignolo, Robert J., Baujat, Geneviève, Hsiao, Edward C., Keen, Richard, Wilson, Amy, Packman, Jeff, Strahs, Andrew L., Grogan, Donna R., Kaplan, Frederick S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Clinical Trials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804935/ https://www.ncbi.nlm.nih.gov/pubmed/35854638 http://dx.doi.org/10.1002/jbmr.4655

Ejemplares similares

Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva
por: Pignolo, Robert J., et al.
Publicado: (2023)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome
por: Pignolo, Robert J., et al.
Publicado: (2020)

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization
por: Pignolo, Robert J., et al.
Publicado: (2021)

SUN-344 Patients with Fibrodysplasia Ossificans Progressiva Have an Increased Prevalence of Cardiac Conduction Abnormalities
por: Kou, Samuel, et al.
Publicado: (2020)

Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes
por: Pignolo, Robert J., et al.
Publicado: (2019)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
por: Pignolo, Robert J, et al.
Publicado: (2011)

Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes
por: Pignolo, Robert J., et al.
Publicado: (2019)

Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective
por: Pignolo, Robert J., et al.
Publicado: (2022)

PSAT180 Fibrodysplasia Ossificans Progressiva (FOP) A Case Series
por: Almonaei, Khulod, et al.
Publicado: (2022)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases
por: Baujat, Geneviève, et al.
Publicado: (2017)

Compartment Syndrome of the Thigh in a Patient with Fibrodysplasia Ossificans Progressiva
por: Kaplan, Frederick S., et al.
Publicado: (2020)

Clinical, evolution and therapeutical considerations upon a case of fibrodysplasia ossificans progressiva (FOP)
por: Rogoveanu, O, et al.
Publicado: (2013)

MON-348 Surgical Management of Bilateral Hip Fracture in a Patient with Fibrodysplasia Ossificans Progressiva Treated with Palovarotene
por: Singh, Sukhmani, et al.
Publicado: (2020)

Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

Crohn's Disease in a Patient With Fibrodysplasia Ossificans Progressiva
por: Havlichek, Daniel, et al.
Publicado: (2022)

Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles
por: Eekhoff, Elisabeth M.W., et al.
Publicado: (2022)

The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva
por: Towler, O. Will, et al.
Publicado: (2020)

Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
por: Padilha, Elias C., et al.
Publicado: (2019)

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis
por: Kaplan, Frederick S., et al.
Publicado: (2012)

Patients with ACVR1(R206H) mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva
por: Kou, Samuel, et al.
Publicado: (2020)

ODP108 Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Phase III Open-Label PIVOINE Rollover Trial
por: Artyomenko, Alex, et al.
Publicado: (2022)

Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva
por: Khan, Fatima, et al.
Publicado: (2021)

Longitudinal Evaluation of Pain, Flare‐Up, and Emotional Health in Fibrodysplasia Ossificans Progressiva: Analyses of the International FOP Registry
por: Peng, Ke, et al.
Publicado: (2019)

Recent Topics in Fibrodysplasia Ossificans Progressiva
por: Katagiri, Takenobu, et al.
Publicado: (2018)

“I Can’t Take off My Shirt or Do My Own Hair”—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP)
por: Markowitz, Jessica T., et al.
Publicado: (2022)

Whole-body Computed Tomography Versus Dual Energy X‑ray Absorptiometry for Assessing Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva
por: Warner, Sarah E., et al.
Publicado: (2021)

Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report
por: Singh, Sukhmani, et al.
Publicado: (2020)

Quality of life of patients with fibrodysplasia ossificans progressiva
por: Ortiz-Agapito, Fernando, et al.
Publicado: (2015)

Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva
por: Colmenares-Bonilla, Douglas, et al.
Publicado: (2018)

Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis
por: De Brasi, Daniele, et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva and Pregnancy: A Case Series and Review of the Literature
por: Forrest, Alexandra D., et al.
Publicado: (2022)

Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
por: Di Rocco, Maja, et al.
Publicado: (2023)

Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery
por: Yang, Yeon-Suk, et al.
Publicado: (2022)

Limb specific Acvr1‐knockout during embryogenesis in mice exhibits great toe malformation as seen in Fibrodysplasia Ossificans Progressiva (FOP)
por: Hildebrand, Laura, et al.
Publicado: (2019)

The Diversity of the Clinical Phenotypes in Patients With Fibrodysplasia Ossificans Progressiva
por: Al Kaissi, Ali, et al.
Publicado: (2016)

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
por: Ventura, Francesc, et al.
Publicado: (2021)

Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives
por: Smilde, Bernard J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7iu9r6ghp3to3hcje42i7lc4n